Evidence map›Paper›PMID 36935555›Full record

SynthesisAmerican journal of men's health

Age-Dependent Relationships Between Disease Risk and Testosterone Levels: Relevance to COVID-19 Disease.

Michael Muehlenbein, Jeffrey Gassen, Tomasz Nowak, Alexandria Henderson, Brooke Morris, Sally Weaver, Erich Baker

Open access · goldAbstract readMeta-Analysis
In one paragraph

Synthesis in American journal of men's health. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.6field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Michael MuehlenbeinBaylor University, Waco, TX, USA.ORCID 0000-0003-1332-6264
Jeffrey GassenBaylor University, Waco, TX, USA.
Tomasz NowakBaylor University, Waco, TX, USA.
Alexandria HendersonBaylor University, Waco, TX, USA.
Brooke MorrisBaylor University, Waco, TX, USA.
Sally WeaverWaco Family Medicine, Waco, TX, USA.
Erich BakerBaylor University, Waco, TX, USA.
Baylor University · USCenter for Occupational Research and Development · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Testosterone levels in men appear to be prognostic of a number of disease outcomes, including severe COVID-19 disease. Testosterone levels naturally decline with age and are lower in individuals with a number of comorbidities and chronic conditions. Low testosterone may therefore be both a cause and a consequence of illness, including COVID-19 disease. The present project examines whether preexisting conditions for severe COVID-19 disease were themselves related to serum-free testosterone levels in men who had not been infected with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus. A clinical risk score for severe COVID-19 disease was computed based on the results of previously published meta-analyses and cohort studies, and relationships between this score and testosterone levels were tested in 142 men ages 19 to 82 years. Greater burden of preexisting conditions for severe COVID-19 disease was related to lower testosterone levels among men younger than 40 years of age. In older men, the decrease in testosterone that accompanies aging attenuated the effect of the clinical risk score on free testosterone levels. Given that older age itself is a predictor of COVID-19 disease severity, these results together suggest that the presence of preexisting conditions may confound the relationship between testosterone levels and COVID-19 disease outcomes in men. Future research examining relationships among testosterone and outcomes related to infectious and chronic diseases should consider potential confounds, such as the role of preexisting conditions.

Indexed as

COVID-19AdultAgedAged, 80 and overChronic DiseaseComorbidityHumansMaleMiddle AgedRisk FactorsSARS-CoV-2TestosteroneYoung AdultTestosteroneagingandrogenschronic diseaseclinical riskcomorbidityCOVID-19

Identifiers

PMID36935555
PMCPMC10028446
OpenAlexW4327894144

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.